NCT06111235: A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT
- State
- Under way
- Phase
- Phase 3
- People
- 367 taking part
- Started
- 14 Dec 2023
- Primary completion
- Nov 2026
- Arms
- Cretostimogene after TURBT
- Results
- None posted
- 1 Nov 2023: Trial registered
- 14 Dec 2023: Trial started